Julie E. Bolding
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Sirtuins and Resveratrol in Medicine 6
-
- Autophagy in Disease and Therapy 4
- Co-authors
- Christian A. Olsen (6 shared papers)Alexander L. Nielsen (4 shared papers)Michael Bæk (3 shared papers)Jinjun Gao (1 shared paper)Di Zhang (1 shared paper)Wenchao Liu (1 shared paper)Lu Yang (1 shared paper)Yingming Zhao (1 shared paper)
- Journals
- Angewandte Chemie International Edition (3 papers)Science Advances (1 paper)Angewandte Chemie (2 papers)
- Partner nations
- DenmarkSwitzerlandAustralia
In The Last Decade
Julie E. Bolding
6 papers receiving 569 citations
Julie E. Bolding's Hit Papers
Peers
Comparison fields: 5 of 58
- Geriatrics and Gerontology 55
- Cancer Research 165
- Physiology 23
- Molecular Biology 338
- Immunology 56
Countries citing papers authored by Julie E. Bolding
This map shows the geographic impact of Julie E. Bolding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie E. Bolding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie E. Bolding more than expected).
Fields of papers citing papers by Julie E. Bolding
This network shows the impact of papers produced by Julie E. Bolding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie E. Bolding. The network helps show where Julie E. Bolding may publish in the future.
Co-authors
The 23 scholars most cited alongside Julie E. Bolding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Class I histone deacetylases (HDAC1–3) are histone lysine delactylases Hit paper breakdown → | 2022 | 494 |
| 2 | 2022 | 37 | |
| 3 | 2022 | 25 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 1 |
About Julie E. Bolding
Julie E. Bolding is a scholar working on Geriatrics and Gerontology, Epidemiology, Physiology, Oncology and Molecular Biology, having authored 6 papers that have together received 571 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (6 papers), Autophagy in Disease and Therapy (4 papers), PARP inhibition in cancer therapy (2 papers), Calcium signaling and nucleotide metabolism (2 papers), Adenosine and Purinergic Signaling (2 papers), Toxin Mechanisms and Immunotoxins (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Geriatrics and Gerontology (55 citations), Cancer Research (165 citations), Physiology (23 citations), Molecular Biology (338 citations) and Immunology (56 citations). Julie E. Bolding has collaborated with scholars based in Denmark, Switzerland and Australia. Frequent co-authors include Christian A. Olsen, Alexander L. Nielsen, Michael Bæk, Jinjun Gao, Di Zhang, Wenchao Liu, Lu Yang, Yingming Zhao, Wei Wei and Daniela Danková. Their work appears in journals such as Angewandte Chemie International Edition, Science Advances and Angewandte Chemie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.